Society For Translational Oncology Inc is located in Durham, NC. The organization was established in 2009. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. As of 12/2021, Society For Translational Oncology Inc employed 2 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Society For Translational Oncology Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Society For Translational Oncology Inc generated $1.2m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 3.4% each year. All expenses for the organization totaled $554.3k during the year ending 12/2021. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
PROMOTE EDUCATION OF ONCOLOGISTS BY PROVIDING PUBLICATIONS, MEETINGS, AND ENDURING MATERIALS THAT SERVE TO SHORTEN THE "TRANSLATIONAL GAP" BETWEEN DISCOVERY AND DEPLOYMENT OF NEW TREATMENTS TO IMPROVE PATIENT CARE. THE FOUNDATION OF STO'S EDUCATIONAL INTERVENTIONS IS THE IMPROVEMENT OF PHYSICIAN COMPETENCIES AND STRATEGIES FOR SCREENING, PREVENTION, DIAGNOSIS, TREATMENT, AND MANAGEMENT OF PATIENTS WITH CANCER; AND ENHANCEMENT OF PERFORMANCE IN PRACTICE. STO IS A NONPROFIT ORGANIZATION DEDICATED TO THE CONTINUED EDUCATION OF ITS MEMBERS AND CANCER CAREGIVERS AND TO THE IMPROVEMENT IN THE QUALITY AND SAFETY OF CARE FOR THE PATIENT WITH CANCER. THE EDUCATIONAL CONTENT OF STO FOCUSES ON MEDICAL, RADIATION, AND SURGICAL ONCOLOGY. EDUCATION IS DISSEMINATED THROUGH LIVE CONFERENCES, WORKSHOPS, INTERNET WEBCASTS, AND JOURNAL-BASED ARTICLES. ITS AUDIENCE IS COMPRISED OF MEDICAL, RADIATION, AND SURGICAL ONCOLOGISTS, NURSE, RESEARCHERS, AND OTHER HEALTH PROFESSIONALS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RACIAL DISPARITIES IN CANCER CARE: THE FIVE-PART SERIES BEGAN IN THE FALL OF 2021 AND WILL CONCLUDE AT THE END OF 2022. THIS EDUCATIONAL INITIATIVE IS COMPRISED OF THREE JOURNAL CONTINUING MEDICAL EDUCATION ARTICLES; A LIVE WEBINAR; AN ENDURING WEBINAR, AND AN INFOGRAPHIC ALL POSTED ON THE MYCME PLATFORM. THE FOCUS OF THE SERIES IS DESIGNED TO ENHANCE AWARENESS OF RACIAL DISPARITIES AND THEIR IMPACT. ACTIVITIES EMPHASIZED ACCESS TO CARE, IMPROVED HEALTHCARE PROVIDER - PATIENT COMMUNICATION, AND MANAGEMENT OF IMMUNE RELATED ADVERSE EVENTS (IRAES).
THE 2021 CHABNER COLLOQUIUM-MAP SERIES IS DESIGNED TO MEET THE EDUCATIONAL NEEDS OF PHYSICIANS AND SCIENTISTS IN ACADEMIC AND PRACTICE SETTINGS WHO WISH TO ADVANCE THEIR KNOWLEDGE OF NEW RESEARCH INTO TREATMENTS TO IMPROVE THEIR COMPETENCE IN THE CARE CANCER PATIENTS. THIS PROGRAM IS PROVIDED IN JOINT PROVIDERSHIP WITH STO AND MASSACHUSETTS GENERAL HOSPITAL. IN 2021 THIS SERIES WAS PRESENTED VIA 8 RECORDED WEBINARS AND AVAILABLE FOR CME CREDIT ON OUR RIEVENT PLATFORM. THE FOCUS ON THE 2021 SERIES INCLUDED GENOMICS, GENOMIC REPORTS AND THERAPEUTIC APPLICATION ALLOWING ACCELERATION OF THE CLINICAL DEVELOPMENT AND APPLICATION O PRECISION DIAGNOSTICS AND THERAPIES FOR PATIENTS, ULTIMATELY IMPROVING OUTCOMES.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Kenneth Lee Secretary | OfficerTrustee | 1 | $0 |
John Crumpler Board Chairman | OfficerTrustee | 1 | $0 |
David Jessen Trasurer | OfficerTrustee | 2 | $0 |
Jayne Gyrtler Cme Director | Officer | 2 | $0 |
Bruce Chabner Chair Education Council | Officer | 2 | $0 |
Martin Murphy Board Member | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $18,298 |
All other contributions, gifts, grants, and similar amounts not included above | $1,128,967 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $1,147,265 |
Total Program Service Revenue | $23,046 |
Investment income | $6,107 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,176,418 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $37,990 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $5,394 |
Fees for services: Management | $0 |
Fees for services: Legal | $4,990 |
Fees for services: Accounting | $49,306 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $111 |
Fees for services: Other | $292,351 |
Advertising and promotion | $35,525 |
Office expenses | $1,229 |
Information technology | $66,593 |
Royalties | $0 |
Occupancy | $0 |
Travel | $32,276 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $2,549 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $107 |
Insurance | $1,315 |
All other expenses | $0 |
Total functional expenses | $554,292 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $43,729 |
Savings and temporary cash investments | $170,442 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $2,037 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $1,151,780 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $1,367,988 |
Accounts payable and accrued expenses | $27,472 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $47,000 |
Total liabilities | $74,472 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $1,293,516 |
Total liabilities and net assets/fund balances | $1,367,988 |
Over the last fiscal year, we have identified 1 grants that Society For Translational Oncology Inc has recieved totaling $5,000.
Awarding Organization | Amount |
---|---|
North Carolina Biotechnology Center Research Triangle Park, NC PURPOSE: BIOTECHNOLOGY MEETING GRANT | $5,000 |
Organization Name | Assets | Revenue |
---|---|---|
American Institute For Cancer Research Arlington, VA | $18,214,497 | $14,242,691 |
Prevent Cancer Foundation Alexandria, VA | $19,123,889 | $9,204,793 |
Chordoma Foundation Durham, NC | $6,529,695 | $3,085,754 |
Reelin For Research Inc Greensboro, NC | $638,760 | $704,128 |
Scott Hamilton Cares Foundation Inc Franklin, TN | $1,663,491 | $1,390,768 |
Glioblastoma Foundation Inc Durham, NC | $1,523,936 | $1,253,574 |
Chance For Life Alexandria, VA | $1,211,933 | $982,944 |
Society For Translational Oncology Inc Durham, NC | $1,367,988 | $1,176,418 |
Friends For An Earlier Breast Cancer Test Inc Greensboro, NC | $239,976 | $461,731 |
The Brassica Foundation For Chemopr Otection Research Inc Mclean, VA | $239,523 | $198,133 |
She Rocks Inc Wilmington, NC | $54,964 | $219,948 |
Rare Cancer Research Foundation Durham, NC | $1,051,579 | $1,072,853 |